Dr. Ning S. Yang
Neurology (Neurology Physician)
4450 Union St # 201
Johnstown, CO 80534
Who else practices at this address →
Weld County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University (2012)
- Years since graduation
- 14
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 277
Licensed in Colorado since 2017, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Medical school: Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University
- 2012Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
CO license DR.0058588 (first issued 2017; active) -
Neuromuscular Medicine (Psychiatry & Neurology) Physician
CO license DR.0058588 (first issued 2017; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Poudre Valley Hospital Fort Collins, CO
- Medical Center of the Rockies Loveland, CO
- Uchealth Greeley Hospital Greeley, CO
- Longs Peak Hospital Longmont, CO
Medical groups
- Advanced Neurology of Colorado LLC (7 clinicians)
- Front Range Neurology, PLLC (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 277
- Services billed
- 17,763
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Needle measurement of electrical activity in arm or leg muscles, complete study | 80 | 48 |
| Established patient office or other outpatient visit, 30-39 minutes | 76 | 57 |
| Established patient office or other outpatient visit, 40-54 minutes | 70 | 47 |
| Established patient office or other outpatient visit, 20-29 minutes | 46 | 40 |
| New patient office or other outpatient visit, 45-59 minutes | 45 | 45 |
| Nerve conduction, 7-8 studies | 30 | 30 |
| New patient office or other outpatient visit, 60-74 minutes | 29 | 29 |
| Nerve conduction, 5-6 studies | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Johnstown, CO | 148 |
| Donepezil Hcl Other prescribers in Johnstown, CO | 63 |
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Johnstown, CO | 50 |
| Gammaked (immune globul g/gly/iga avg 46) | 45 |
| Pyridostigmine Bromide Other prescribers in Johnstown, CO | 44 |
| Pregabalin Other prescribers in Johnstown, CO | 43 |
| Sodium Chloride (0.9 % sodium chloride) Other prescribers in Johnstown, CO | 39 |
| Prednisone Other prescribers in Johnstown, CO | 34 |
| Levetiracetam Other prescribers in Johnstown, CO | 32 |
| Propranolol Hcl Other prescribers in Johnstown, CO | 28 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 38 companies reported 294 payments worth $57,085 in total to this clinician.
| Alexion Pharmaceuticals, Inc. | $23,703 |
|---|---|
| Argenx US, Inc. | $12,871 |
| Amgen Inc. | $8,583 |
| UCB, Inc. | $4,158 |
| Merck Kgaa | $1,820 |
| Janssen Biotech, Inc. | $988 |
| Tg Therapeutics, Inc. | $871 |
| AbbVie Inc. | $627 |
| Compensation for services other than consulting (speaking, faculty) | $32,871 |
|---|---|
| Consulting Fee | $12,075 |
| Food and Beverage | $7,697 |
| Travel and Lodging | $4,443 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Feb 11, 2025 | Consulting Fee UPLIZNA · Inflammation/Rare Disease | $3,850 |
| Argenx US, Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) VYVGART · Immunology | $3,600 |
| Alexion Pharmaceuticals, Inc. Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $3,500 |
| Alexion Pharmaceuticals, Inc. Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $2,800 |
| Alexion Pharmaceuticals, Inc. Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $2,800 |
| Amgen Inc. Feb 11, 2025 | Consulting Fee UPLIZNA · Inflammation/Rare Disease | $2,750 |
| Argenx US, Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) VYVGART · Immunology | $2,400 |
| Alexion Pharmaceuticals, Inc. Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $2,100 |
| Alexion Pharmaceuticals, Inc. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $2,100 |
| Alexion Pharmaceuticals, Inc. Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $2,100 |
All 57 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Argenx US, Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) VYVGART · Immunology | $2,400 |
| UCB, Inc. Nov 20, 2025 | Consulting Fee Rystiggo · Neurology | $1,680 |
| Argenx US, Inc. Nov 20, 2025 | Travel and Lodging VYVGART · Immunology · travel to Cheyenne, WY | $70.14 |
| Argenx US, Inc. Nov 6, 2025 | Consulting Fee VYVGART HYTRULO · Neurology | $1,800 |
| Argenx US, Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) VYVGART · Immunology | $3,600 |
| Argenx US, Inc. Sep 4, 2025 | Travel and Lodging VYVGART · Immunology · travel to Albuquerque, NM | $86.66 |
| Argenx US, Inc. Sep 4, 2025 | Travel and Lodging VYVGART · Immunology · travel to Albuquerque, NM | $53.40 |
| Argenx US, Inc. Sep 4, 2025 | Travel and Lodging VYVGART · Immunology · travel to Albuquerque, NM | $35.00 |
| Amgen Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) | $688 |
| Argenx US, Inc. Aug 21, 2025 | Travel and Lodging VYVGART · Immunology · travel to Albuquerque, NM | $289 |
| Argenx US, Inc. Aug 21, 2025 | Travel and Lodging VYVGART · Immunology · travel to Albuquerque, NM | $149 |
| Argenx US, Inc. Aug 21, 2025 | Travel and Lodging VYVGART · Immunology · travel to Albuquerque, NM | $55.00 |
| UCB, Inc. Aug 5, 2025 | Compensation for services other than consulting (speaking, faculty) Zilbrysq · Neurology | $200 |
| Janssen Biotech, Inc. Aug 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $833 |
| UCB, Inc. Jul 3, 2025 | Compensation for services other than consulting (speaking, faculty) Zilbrysq · Neurology | $1,050 |
| Alexion Pharmaceuticals, Inc. Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $2,100 |
| Alexion Pharmaceuticals, Inc. Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $2,100 |
| Alexion Pharmaceuticals, Inc. Jun 27, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Lone Tree, CO | $119 |
| Alexion Pharmaceuticals, Inc. Jun 27, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Lone Tree, CO | $119 |
| Alexion Pharmaceuticals, Inc. Jun 27, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Lone Tree, CO | $11.60 |
| Alexion Pharmaceuticals, Inc. Jun 19, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $1,750 |
| Argenx US, Inc. Jun 17, 2025 | Compensation for services other than consulting (speaking, faculty) VYVGART · Immunology | $1,600 |
| Argenx US, Inc. Jun 17, 2025 | Travel and Lodging VYVGART · Immunology · travel to Windsor, CO | $17.08 |
| Alexion Pharmaceuticals, Inc. Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $2,800 |
| Alexion Pharmaceuticals, Inc. Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $2,800 |
| Alexion Pharmaceuticals, Inc. Jun 5, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Grand Junction, CO · in-kind Company’s descriptionSpeaker Expenses | $469 |
| Alexion Pharmaceuticals, Inc. Jun 5, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Grand Junction, CO · in-kind Company’s descriptionSpeaker Expenses | $469 |
| Alexion Pharmaceuticals, Inc. Jun 5, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Grand Junction, CO · in-kind Company’s descriptionSpeaker Expenses | $297 |
| Alexion Pharmaceuticals, Inc. Jun 5, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Grand Junction, CO · in-kind Company’s descriptionSpeaker Expenses | $297 |
| Alexion Pharmaceuticals, Inc. Jun 5, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Grand Junction, CO | $86.66 |
| Alexion Pharmaceuticals, Inc. Jun 5, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Grand Junction, CO | $86.66 |
| Alexion Pharmaceuticals, Inc. Jun 5, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Denver, CO | $35.00 |
| Alexion Pharmaceuticals, Inc. Jun 5, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Denver, CO | $35.00 |
| Alexion Pharmaceuticals, Inc. Jun 5, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Grand Junction, CO | $23.20 |
| Alexion Pharmaceuticals, Inc. Jun 5, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Grand Junction, CO | $14.19 |
| Alexion Pharmaceuticals, Inc. Jun 5, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Grand Junction, CO | $14.19 |
| Argenx US, Inc. May 30, 2025 | Compensation for services other than consulting (speaking, faculty) VYVGART · Immunology | $600 |
| UCB, Inc. May 15, 2025 | Compensation for services other than consulting (speaking, faculty) Rystiggo · Neurology | $1,050 |
| Argenx US, Inc. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,600 |
| Alexion Pharmaceuticals, Inc. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $2,100 |
| Alexion Pharmaceuticals, Inc. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $2,100 |
| Alexion Pharmaceuticals, Inc. Mar 28, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Lakewood, CO | $94.64 |
| Alexion Pharmaceuticals, Inc. Mar 28, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Lakewood, CO | $94.64 |
| Alexion Pharmaceuticals, Inc. Mar 27, 2025 | Consulting Fee ULTOMIRIS · Rare Disease | $175 |
| Alexion Pharmaceuticals, Inc. Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $3,500 |
| Amgen Inc. Feb 18, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to HOUSTON, TX | $147 |
| Amgen Inc. Feb 11, 2025 | Consulting Fee UPLIZNA · Inflammation/Rare Disease | $3,850 |
| Amgen Inc. Feb 11, 2025 | Consulting Fee UPLIZNA · Inflammation/Rare Disease | $2,750 |
| Alexion Pharmaceuticals, Inc. Feb 8, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Nashville, TN · in-kind Company’s descriptionSpeaker Expenses | $223 |
| Alexion Pharmaceuticals, Inc. Feb 8, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Nashville, TN · in-kind Company’s descriptionSpeaker Expenses | $162 |
| Alexion Pharmaceuticals, Inc. Feb 8, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Denver, CO | $93.80 |
| Alexion Pharmaceuticals, Inc. Feb 8, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Denver, CO | $60.00 |
| Alexion Pharmaceuticals, Inc. Feb 8, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Denver, CO | $11.60 |
| Alexion Pharmaceuticals, Inc. Feb 7, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Nashville, TN · in-kind Company’s descriptionSpeaker Expenses | $173 |
| Amgen Inc. Jan 31, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to HOUSTON, TX · in-kind | $402 |
| Amgen Inc. Jan 31, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to HOUSTON, TX · in-kind | $148 |
| Merck Kgaa Jan 14, 2025 | Consulting FeeCompany’s descriptionAdvisory Board Participation (Fee For Service) | $1,820 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $53,542 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Ipsen Innovation · Active, not recruiting · NCT06625060 - Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
AbbVie Inc. · Enrolling by invitation · NCT05707949 - Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Episodic Migraine
AbbVie Inc. - Long Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies
Alexion Pharmaceuticals, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.